← Eichor
Condition: Hmg Coa Reductase Inhibitor Toxicity Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Hmg Coa Reductase Inhibitor Toxicity

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted
Phase 2 · 10 location(s) · Rutgers, The State University of New Jersey · NCT05559164Low Dose Rosuvastatin Plus Ezetimibe Versus High-dose Rosuvastatin in AMI
Phase 4 · 7 location(s) · Kiyuk Chang, MD,PhD · NCT04499859
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.